Sage Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
55.50
|
|
Average Rating
|
3.70
|
|
# Strong Buys
|
6
|
|
# Buys
|
4
|
|
# Holds
|
13
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.21
|
-2.31
|
-0.10
|
-4.52%
|
|
2022-06-30
|
-2.15
|
-2.13
|
0.02
|
0.93%
|
|
2022-03-31
|
-2.04
|
-2.07
|
-0.03
|
-1.47%
|
|
2021-12-31
|
-2.17
|
-2.12
|
0.05
|
2.30%
|
|
2021-09-30
|
-1.85
|
-2.21
|
-0.36
|
-19.46%
|
|
2021-06-30
|
-1.69
|
-1.83
|
-0.14
|
-8.28%
|
|
2021-03-31
|
-1.91
|
-1.64
|
0.27
|
14.14%
|
|
2020-12-31
|
-0.35
|
18.19
|
18.54
|
5297.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.51
|
|
2021-12-31
|
-7.80
|
|
2020-12-31
|
11.09
|
|
2019-12-31
|
-13.38
|
|
2018-12-31
|
-8.05
|
|
2017-12-31
|
-7.12
|
|
2016-12-31
|
-4.70
|
|
2015-12-31
|
-3.39
|
|
2014-12-31
|
-5.64
|